Targeting monoamine oxidase A in advanced prostate cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 11, 2010, Pages 1761-1771

  Flamand, Vincent ^a,b   Zhao, Hongjuan ^a   Peehl, Donna M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Androgen; Differentiation; Monoamine oxidase; Oncogenes; Prostate cancer

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANDROGEN; BETA CATENIN; CLORGYLINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTOME; AMINE OXIDASE (FLAVIN CONTAINING); RNA;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ANIMAL; CANCER STAGING; CANCER TRANSPLANTATION; CELL DIVISION; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VETERINARY; XENOGRAFT;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CLORGYLINE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MONOAMINE OXIDASE; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS;

EID: 77957551456     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0835-6     Document Type: Article

References (34)

1. SH Chiou HH Ku TH Tsai HL Lin LH Chen CS Chien LL Ho CH Lee YL Chang 2006 Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway Br J Pharmacol 148 587 598 1:CAS:528:DC%2BD28XmsVansrc%3D 10.1038/sj.bjp.0706766 16702990 (Pubitemid 43993050)
2. RN Cooper A Irintchev JP Di Santo M Zweyer JE Morgan TA Partridge GS Butler-Browne V Mouly A Wernig 2001 A new immunodeficient mouse model for human myoblast transplantation Hum Gene Ther 12 823 831 1:CAS:528:DC%2BD3MXjsVegt7g%3D 10.1089/104303401750148784 11339898 (Pubitemid 32692347)
3. CJ Creighton 2008 Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors PLoS One 3 e1816 10.1371/journal.pone.0001816 18350153 (Pubitemid 351917374)
4. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:RESEARCH0032
5. U Fischer AK Struss D Hemmer A Michel W Henn WI Steudel E Meese 2001 PHF3 expression is frequently reduced in glioma Cytogenet Cell Genet 94 131 136 1:CAS:528:DC%2BD38XhtlGlsLo%3D 10.1159/000048804 11856869
6. MA Fox CL Jensen PS Gallagher DL Murphy 2007 Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice Neuropharmacology 53 643 656 1:CAS:528:DC%2BD2sXhtFekurbE 10.1016/j.neuropharm.2007.07.009 17765930 (Pubitemid 47513171)
7. M Han AW Partin CR Pound JI Epstein PC Walsh 2001 Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience Urol Clin North Am 28 555 565 1:STN:280:DC%2BD3Mrktlaluw%3D%3D 10.1016/S0094-0143(05)70163-4 11590814 (Pubitemid 32916759)
8. A Heidenreich G Aus M Bolla S Joniau VB Matveev HP Schmid F Zattoni 2008 EAU guidelines on prostate cancer Eur Urol 53 68 80 10.1016/j.eururo.2007.09.002 17920184 (Pubitemid 350166735)
9. D Ilic D O'Connor S Green T Wilt 2007 Screening for prostate cancer:a Cochrane systematic review Cancer Causes Control 18 279 285 10.1007/s10552-006- 0087-6 17206534 (Pubitemid 46356208)
10. JE Johansson O Andren SO Andersson PW Dickman L Holmberg A Magnuson HO Adami 2004 Natural history of early, localized prostate cancer JAMA 291 2713 2719 1:CAS:528:DC%2BD2cXkvVeqs7c%3D 10.1001/jama.291.22.2713 15187052 (Pubitemid 38725420)
11. N Kitanaka J Kitanaka M Takemura 2006 Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor Neurochem Res 31 829 837 1:CAS:528:DC%2BD28Xnt1aitL0%3D 10.1007/s11064-006-9087-x 16794857 (Pubitemid 44114817)
12. S Korenchuk JE Lehr L MClean YG Lee S Whitney R Vessella DL Lin KJ Pienta 2001 VCaP, a cell-based model system of human prostate cancer In Vivo 15 163 168 1:STN:280:DC%2BD3MrgsVOgsg%3D%3D 11317522
13. AY Liu LD True 2002 Characterization of prostate cell types by CD cell surface molecules Am J Pathol 160 37 43 1:CAS:528:DC%2BD38XnvFeitg%3D%3D 11786396
14. J Ma M Yoshimura E Yamashita A Nakagawa A Ito T Tsukihara 2004 Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors J Mol Biol 338 103 114 1:CAS:528:DC%2BD2cXisFyks74%3D 10.1016/j.jmb.2004.02.032 15050826 (Pubitemid 38429789)
15. KJ O'Malley R Dhir JB Nelson J Bost Y Lin Z Wang 2009 The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia Prostate 69 1716 1723 10.1002/pros.21034 19676094
16. Peehl D (1992) Culture of human prostatic epithelial cells. In: Freshney R (ed) Culture of epithelial cells. New York, Wiley-Liss
17. DM Peehl RG Sellers 2000 Cultured stromal cells:an in vitro model of prostatic mesenchymal biology Prostate 45 115 123 1:CAS:528:DC%2BD3cXnsFGisro%3D 10.1002/1097-0045(20001001)45:2<115::AID-PROS5>3.0.CO;2-C 11027410
18. DM Peehl M Coram H Khine S Reese R Nolley H Zhao 2008 The significance of monoamine oxidase-A expression in high grade prostate cancer J Urol 180 2206 2211 10.1016/j.juro.2008.07.019 18804811
19. D Pflueger DS Rickman A Sboner S Perner CJ LaFargue MA Svensson BJ Moss N Kitabayashi Y Pan A de la Taille, et al. 2009 N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer Neoplasia 11 804 811 1:CAS:528:DC%2BD1MXoslKiurg%3D 19649210
20. P Pietrangeli B Mondovi 2004 Amine oxidases and tumors Neurotoxicology 25 317 324 1:CAS:528:DC%2BD3sXhtVSjtLjF 10.1016/S0161-813X(03)00109-8 14697906 (Pubitemid 38044192)
21. MA Rubin S Varambally R Beroukhim SA Tomlins DR Rhodes PL Paris MD Hofer M Storz-Schweizer R Kuefer JA Fletcher, et al. 2004 Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer Cancer Res 64 3814 3822 1:CAS:528:DC%2BD2cXksVKgu7o%3D 10.1158/0008-5472.CAN-03-3881 15172988 (Pubitemid 38697290)
22. WR Sellers M Loda 2002 The EZH2 polycomb transcriptional repressor-a marker or mover of metastatic prostate cancer? Cancer Cell 2 349 350 1:CAS:528:DC%2BD38XptlaltbY%3D 10.1016/S1535-6108(02)00187-3 12450788 (Pubitemid 41039099)
23. G Sherlock T Hernandez-Boussard A Kasarskis G Binkley JC Matese SS Dwight M Kaloper S Weng H Jin CA Ball, et al. 2001 The Stanford microarray database Nucleic Acids Res 29 152 155 1:CAS:528:DC%2BD3MXjtlWnu7o%3D 10.1093/nar/29.1.152 11125075
24. JC Shih K Chen MJ Ridd 1999 Monoamine oxidase:from genes to behavior Annu Rev Neurosci 22 197 217 1:CAS:528:DyaK1MXhvFemsrk%3D 10.1146/annurev.neuro.22. 1.197 10202537 (Pubitemid 29144886)
25. DM Thomas DM Francescutti-Verbeem DM Kuhn 2008 The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity J Neurochem 105 605 616 1:CAS:528:DC%2BD1cXlsl2htbY%3D 10.1111/j.1471-4159.2007. 05155.x 18088364 (Pubitemid 351562714)
26. SA Tomlins DR Rhodes S Perner SM Dhanasekaran R Mehr XW Sun S Varambally X Cao J Tchinda R Kuefer, et al. 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 644 648 1:CAS:528:DC%2BD2MXhtFChsLjJ 10.1126/science.1117679 16254181 (Pubitemid 41528150)
27. L True I Coleman S Hawley CY Huang D Gifford R Coleman TM Beer E Gelmann M Datta E Mostaghel, et al. 2006 A molecular correlate to the Gleason grading system for prostate adenocarcinoma Proc Natl Acad Sci USA 103 10991 10996 1:CAS:528:DC%2BD28XnsFentL8%3D 10.1073/pnas.0603678103 16829574 (Pubitemid 44148406)
28. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 5116 5121 1:CAS:528:DC%2BD3MXjt1Ons7w%3D 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
29. Q Wang W Li Y Zhang X Yuan K Xu J Yu Z Chen R Beroukhim H Wang M Lupien, et al. 2009 Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Cell 138 245 256 1:CAS:528: DC%2BD1MXhtVSgtrzE 10.1016/j.cell.2009.04.056 19632176
30. MB Youdim D Edmondson KF Tipton 2006 The therapeutic potential of monoamine oxidase inhibitors Nat Rev Neurosci 7 295 309 1:CAS:528: DC%2BD28Xis1Gksrs%3D 10.1038/nrn1883 16552415
31. J Yu Q Cao R Mehra B Laxman SA Tomlins CJ Creighton SM Dhanasekaran R Shen G Chen DS Morris, et al. 2007 Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer Cancer Cell 12 419 431 1:CAS:528:DC%2BD2sXhtl2nur3F 10.1016/j.ccr.2007.10.016 17996646 (Pubitemid 350046407)
32. H Zhao DM Peehl 2009 Tumor-promoting phenotype of CD90(hi) prostate cancer-associated fibroblasts Prostate 69 991 1000 1:CAS:528: DC%2BD1MXns1CktL8%3D 10.1002/pros.20946 19267366
33. H Zhao R Nolley Z Chen SW Reese DM Peehl 2008 Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells Differentiation 76 820 830 1:CAS:528:DC%2BD1cXhtVyrsLzI 10.1111/j.1432-0436. 2007.00263.x 18248494
34. H Zhao V Flamand DM Peehl 2009 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells BMC Med Genomics 2 55 69 10.1186/1755-8794-2-55 19691856